← All companies

ANGO

AngioDynamics, Inc.

ANGO Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$15.17

+0.38 +2.57%

Key statistics

from XBRL data in SEC filings

Market cap

$627M

Revenue (TTM)

$320M

Net income (TTM)

-$36.7M

EPS (TTM)

$-0.88

P/E ratio

—

Dividend yield

—

Free cash flow

$508K

Cash

$53.9M

Total assets

$267M

Gross margin

54.6%

52-week range

$8.36 – $15.41

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K Fiscal year ended 2026-05-31 Jul 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 14, 2026 8-K Other events Apr 23, 2026 10-Q Quarter ended 2026-02-28 Apr 2, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 2, 2026 8-K Director or officer change Feb 3, 2026 8-K Regulation FD disclosure Jan 14, 2026 10-Q Quarter ended 2025-11-30 Jan 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 6, 2026 8-K Shareholder vote results Nov 12, 2025 10-Q Quarter ended 2025-08-31 Oct 2, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 2, 2025 10-K Fiscal year ended 2025-05-31 Jul 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation May 28, 2025 10-Q Quarter ended 2025-02-28 Apr 2, 2025 8-K Regulation FD disclosure Apr 2, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 2, 2025 8-K Regulation FD disclosure Jan 16, 2025 10-Q Quarter ended 2024-11-30 Jan 8, 2025 8-K Regulation FD disclosure Jan 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2025 8-K Director or officer change; Shareholder vote results Nov 15, 2024 10-Q Quarter ended 2024-08-31 Oct 3, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 3, 2024 10-K Fiscal year ended 2024-05-31 Jul 25, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 16, 2024 8-K Results of operations (earnings release) Jul 16, 2024 10-Q Quarter ended 2024-02-29 Apr 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 4, 2024 8-K Entered a material agreement Apr 1, 2024 8-K Director or officer change Feb 13, 2024 8-K Director or officer change Jan 22, 2024 8-K Regulation FD disclosure Jan 11, 2024 10-Q Quarter ended 2023-11-30 Jan 8, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jan 5, 2024 8-K Director or officer change; Shareholder vote results Nov 16, 2023 10-Q Quarter ended 2023-08-31 Oct 5, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Oct 4, 2023 10-K Fiscal year ended 2023-05-31 Aug 3, 2023